Tekrardan Hoşgeldiniz
Cointime'ın Hizmet Şartları'ini kabul etmek ve Cointime'ın Gizlilik Politikası'inin sizin için geçerli olduğunu onaylamak için "Giriş "a tıklayın.
Cointime’a Katıl
Çoktan Hesabın Var mı?
Cointime'ın <a class="underline" href="#term-of-service">Hizmet Şartları</a>'ini kabul etmek ve Cointime'ın a class="underline" href="#privacy-policy">Gizlilik Politikası</a>'inin sizin için geçerli olduğunu onaylamak için "page.Sign up "a tıklayın.
Giriş Yap
Kayıt Ol
Posta kutunuz
Gelen kutunuzu kontrol edin
Giriş yapmak için emaildeki bağlantıya tıklayın.
Kayıt olmak için emaildeki bağlantıya tıklayın.
Porton Advanced Solutions
company
About
Porton Advanced Solutions provide end-to-end process development (PD), analytical development (AD), GMP manufacturing, and testing services.
- 251 - 500
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $80M
- Industries
- Biotechnology,Genetics,Manufacturing,Pharmaceutical,Therapeutics
- Founded date
- Jan 1, 2018
- Number Of Employee
- 251 - 500
- Operating Status
- Active
Porton Advanced Solutions (Porton Advanced) is a CDMO specializing in Cell and Gene Therapy (CGT). To meet the therapeutic product needs of our clients at the pre-clinical, clinical, and commercial stages, we offer end-to-end process development (PD), analytical development (AD), GMP manufacturing, and testing services.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$80M ¥400M
Porton Advanced Solutions has raised a total of
$80M ¥400M
in funding over 2 rounds. Their latest funding was raised on
Aug 21, 2022 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Aug 21, 2022 | Series B | $80M | 4 | — | — | Detail |
| Apr 16, 2021 | Series A | ¥400M | 2 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
5
Porton Advanced Solutions is funded by 5 investors.
China Merchants Securities
and Ruilin Investment
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
China Merchants Securities
|
— | Series B |
|
|
— | Series B |
|
|
— | Series B |
|
|
— | Series B |
|
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
